Concepedia

Dan V. Nicolau

DV

Statistics

Publications

15

Citations

1.2K

H-Index

13

Active since

2002

Affiliations

University of Oxford(Current)

Queensland University of Technology

The University of Queensland

Imperial College London

National Institute for Health and Care Research

Dan V. Nicolau is an author at University of Oxford specializing in pharmacotherapy, respiratory disease, and pulmonology.

ORCID

Publications per year

2002–2022

15

Publications

15

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

Sanjay Ramakrishnan, Dan V. Nicolau, Beverly Langford et al. · The Lancet Respiratory Medicine · 2021 · 434 citations · Full text

, , +13

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Ly‐Mee Yu, Mona Bafadhel, Jienchi Dorward et al. · The Lancet · 2021 · 310 citations · Full text

, , +14

Fungi Use Efficient Algorithms for the Exploration of Microfluidic Networks

Kristi L. Hanson, Dan V. Nicolau, Luisa Filipponi et al. · Small · 2006 · 78 citations

, , +13

Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?

Dan V. Nicolau, Mona Bafadhel · The Lancet Respiratory Medicine · 2020 · 62 citations · Full text

, , +14

The BAD project: data mining, database and prediction of protein adsorption on surfaces

Elena N. Vasina, Ewa Paszek, Dan V. Nicolau et al. · Lab on a Chip · 2008 · 58 citations

, , +17

1–5 of 15